Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in

Advanced Enzyme Technologies Ltd
NSE:ADVENZYMES

Watchlist Manager
Advanced Enzyme Technologies Ltd Logo
Advanced Enzyme Technologies Ltd
NSE:ADVENZYMES
Watchlist
Price: 291.3 INR 1.96% Market Closed
Market Cap: ₹32.6B
Write Note Create Alert Ask AI
Price Target
Loading...
Revenue
Loading...
Operating Income
Loading...
Net Income
Loading...

Wall Street
Price Targets

ADVENZYMES Price Targets Summary
Advanced Enzyme Technologies Ltd

Wall Street analysts forecast ADVENZYMES stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ADVENZYMES is 448.8 INR with a low forecast of 444.4 INR and a high forecast of 462 INR.

ADVENZYMES Lowest Forecast
Wall Street Target
444.4 INR
53% Upside
ADVENZYMES Average Forecast
Wall Street Target
448.8 INR
54% Upside
ADVENZYMES Highest Forecast
Wall Street Target
462 INR
59% Upside
Lowest
Price Target
444.4 INR
53% Upside
Average
Price Target
448.8 INR
54% Upside
Highest
Price Target
462 INR
59% Upside
Advanced Enzyme Technologies Ltd Competitors:
Price Targets
E
EBR
EBR Systems Inc
234% Upside
E
EBR
EBR Systems Inc
234% Upside

Revenue
Forecast

11% / Year
Past Growth
18% / Year
Estimated Growth
Estimates Accuracy
-4%
Average Miss
11% / Year
Past Growth
18% / Year
Estimated Growth
Estimates Accuracy
-4%
Average Miss

For the last 13 years the compound annual growth rate for Advanced Enzyme Technologies Ltd's revenue is 11%. The projected CAGR for the next 3 years is 18%.

What are analyst estimates?

Operating Income
Forecast

8% / Year
Past Growth
18% / Year
Estimated Growth
Estimates Accuracy
-10%
Average Miss
8% / Year
Past Growth
18% / Year
Estimated Growth
Estimates Accuracy
-10%
Average Miss

For the last 13 years the compound annual growth rate for Advanced Enzyme Technologies Ltd's operating income is 8%. The projected CAGR for the next 3 years is 18%.

What are analyst estimates?

Net Income
Forecast

11% / Year
Past Growth
18% / Year
Estimated Growth
Estimates Accuracy
-11%
Average Miss
11% / Year
Past Growth
18% / Year
Estimated Growth
Estimates Accuracy
-11%
Average Miss

For the last 13 years the compound annual growth rate for Advanced Enzyme Technologies Ltd's net income is 11%. The projected CAGR for the next 3 years is 18%.

What are analyst estimates?

See Also

Summary
ADVENZYMES intrinsic value, competitors valuation, and company profile.
DCF Valuation
ADVENZYMES stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ADVENZYMES stock valuation using valuation multiples.
Wall Street Estimates
ADVENZYMES price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ADVENZYMES stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ADVENZYMES's stock price target?
Price Target
448.8 INR

According to Wall Street analysts, the average 1-year price target for ADVENZYMES is 448.8 INR with a low forecast of 444.4 INR and a high forecast of 462 INR.

What is Advanced Enzyme Technologies Ltd's Revenue forecast?
Projected CAGR
18%

For the last 13 years the compound annual growth rate for Advanced Enzyme Technologies Ltd's revenue is 11%. The projected CAGR for the next 3 years is 18%.

What is Advanced Enzyme Technologies Ltd's Operating Income forecast?
Projected CAGR
18%

For the last 13 years the compound annual growth rate for Advanced Enzyme Technologies Ltd's operating income is 8%. The projected CAGR for the next 3 years is 18%.

What is Advanced Enzyme Technologies Ltd's Net Income forecast?
Projected CAGR
18%

For the last 13 years the compound annual growth rate for Advanced Enzyme Technologies Ltd's net income is 11%. The projected CAGR for the next 3 years is 18%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 315,100+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.